Genprex Inc is a biotechnology company focused on developing innovative gene therapy treatments for cancer and diabetes. Their primary aim is to enhance the efficacy of existing therapies and improve patient outcomes through the use of their proprietary Oncoprex immunogene therapy, which targets various types of tumors. The company is dedicated to advancing its promising treatments through clinical trials and aims to address significant unmet medical needs in oncology. With a strong emphasis on research and development, Genprex seeks to create transformative therapies that can benefit patients and improve their quality of life. Read More
The Outbreak: In 2025, the FDA confirmed 134 cases of Salmonella Enteritidis across 10 states, including 38 hospitalizations and one death, traced to August Egg Company’s brown cage-free and organic eggs. Environmental testing revealed the outbreak strain within the company’s laying houses—evidence that contamination originated at the production level, not in downstream distribution or retail.
NEW YORK, NY / ACCESS Newswire / September 30, 2025 / Investor Summit Group is pleased to announce that presentations from the Q3 Virtual Investor Summit are now accessible for on-demand viewing. Investors and attendees who were unable to join the live event can now explore company updates and insights at their convenience.
NEW YORK, NY / ACCESS Newswire / September 16, 2025 / Investor Summit Group, the premier destination for virtual microcap conferences, is proud to announce the schedule for its upcoming Q3 Investor Summit Virtual on Sept 16, 2025.
After the conclusion of the US market's regular session on Friday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
Let's have a look at what is happening on the US markets one hour before the close of the markets on Friday. Below you can find the top gainers and losers in today's session.
As we await the opening of the US market on Friday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
